Status:
COMPLETED
Use of BRASS in Sedated Critically-ill Patients as a Predictable Mortality Factor
Lead Sponsor:
CHU de Reims
Conditions:
Brainstem Response
Eligibility:
All Genders
18+ years
Brief Summary
Sedation is used for 30 to 70 % of all intensive care unit (ICU) patients. Deep sedation can be used for lot of disease like acute respiratory distress syndrome, septic shock. Deep sedation was defin...
Detailed Description
Sedation is used for 30 to 70 % of all intensive care unit (ICU) patients. Deep sedation can be used for lot of disease like acute respiratory distress syndrome, septic shock. Deep sedation was defin...
Eligibility Criteria
Inclusion
- Patient more than 18 years Hospitalized in ICU Without neurologic disorder and/or neurologic pattern Under sedation and mechanical ventilation
Exclusion
- Patients with legal protection No affiliation with the French Health Care system Ongoing pregnancy Inability to obtain consent Not to resuscitate decision Neurologic disorder
Key Trial Info
Start Date :
February 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 26 2019
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03835091
Start Date
February 7 2019
End Date
August 26 2019
Last Update
March 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092